These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 25843158)
1. Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis. Zarzycka B; Nicolaes GA; Lutgens E Expert Rev Clin Pharmacol; 2015 May; 8(3):297-313. PubMed ID: 25843158 [TBL] [Abstract][Full Text] [Related]
2. Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis. Li B; Li W; Li X; Zhou H Curr Pharm Des; 2017; 23(8):1216-1227. PubMed ID: 28034355 [TBL] [Abstract][Full Text] [Related]
3. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Taleb S; Tedgui A; Mallat Z Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818 [TBL] [Abstract][Full Text] [Related]
4. Novel directions in inflammation as a therapeutic target in atherosclerosis. Verweij SL; van der Valk FM; Stroes ES Curr Opin Lipidol; 2015 Dec; 26(6):580-5. PubMed ID: 26382552 [TBL] [Abstract][Full Text] [Related]
5. Adaptive T cell immune responses and atherogenesis. Taleb S; Tedgui A; Mallat Z Curr Opin Pharmacol; 2010 Apr; 10(2):197-202. PubMed ID: 20207195 [TBL] [Abstract][Full Text] [Related]
6. Targeting inflammation in cardiovascular diseases. still a neglected field? Gómez-Guerrero C; Mallavia B; Egido J Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009 [TBL] [Abstract][Full Text] [Related]
14. Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines. Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209109 [TBL] [Abstract][Full Text] [Related]
15. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets. Cole JE; Mitra AT; Monaco C Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937 [TBL] [Abstract][Full Text] [Related]
16. Immune-mediated mechanisms of atherosclerosis and implications for the clinic. Nus M; Mallat Z Expert Rev Clin Immunol; 2016 Nov; 12(11):1217-1237. PubMed ID: 27253721 [TBL] [Abstract][Full Text] [Related]
17. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. Little PJ; Chait A; Bobik A Pharmacol Ther; 2011 Sep; 131(3):255-68. PubMed ID: 21510977 [TBL] [Abstract][Full Text] [Related]
18. The hemostatic system as a regulator of inflammation in atherosclerosis. Koch M; Zernecke A IUBMB Life; 2014 Nov; 66(11):735-44. PubMed ID: 25491152 [TBL] [Abstract][Full Text] [Related]